Press Releases April 23, 2026 04:15 PM

Onity Group Schedules First Quarter 2026 Results Conference Call

Onity Group Announces Date for First Quarter 2026 Earnings Conference Call

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
ONIT

Onity Group Inc. scheduled a conference call for May 5, 2026, to discuss its first quarter 2026 financial results and provide a business update. The company operates as a leading non-bank financial services provider specializing in mortgage servicing and origination through its subsidiary Onity Mortgage Corporation.

Onity Group Schedules First Quarter 2026 Results Conference Call
ONIT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Conference call set for May 5, 2026, to review Q1 operating results and provide business update.
  • Onity Group is a major player in the mortgage servicing and origination sector, serving consumers and business clients.
  • The company uses a technology-driven, customer-centric platform with operations in the US, US Virgin Islands, India, and the Philippines.

WEST PALM BEACH, Fla., April 23, 2026 (GLOBE NEWSWIRE) -- Onity Group Inc. (NYSE: ONIT) (“Onity” or the “Company”) today announced that it will hold a conference call on Tuesday, May 5, 2026 at 8:30 a.m. (ET) to review the Company’s first quarter 2026 operating results and provide a business update.

All interested parties are welcome to participate. You can access the conference call by dialing (800) 267-6316 or (203) 518-9783 approximately 10 minutes prior to the call; please reference the conference ID “Onity.” Participants can also access the conference call through a live audio webcast available from the Shareholder Relations page at onitygroup.com under Events and Presentations.

An investor presentation will accompany the conference call and be available by visiting the Shareholder Relations page at onitygroup.com prior to the call.

A replay of the conference call will be available via the website approximately two hours after the conclusion of the call. A telephonic replay will also be available approximately three hours following the call’s completion through May 19, 2026, by dialing (844) 512-2921 or (412) 317-6671; please reference access code 11161434.

About Onity Group

Onity Group Inc. (NYSE: ONIT) is a leading non-bank financial services company delivering mortgage servicing and originations solutions through Onity Mortgage Corporation. As one of the largest mortgage servicers in the country, we help consumers and business clients achieve their homeownership and financial goals with a wide range of servicing and lending programs powered by a technology-enabled, customer-centric platform. Headquartered in West Palm Beach, Florida, with offices and operations in the United States, the U.S. Virgin Islands, India and the Philippines, we have been serving our customers since 1988. For additional information, please visit onitygroup.com or onitymortgage.com.

For Further Information Contact:

Investors:
Valerie Haertel, VP, Investor Relations
(561) 570-2969
shareholderrelations@onitygroup.com

Media:
Dico Akseraylian, SVP, Corporate Communications
(856) 917-0066
mediarelations@onitygroup.com


Risks

  • Financial performance depends on the housing and mortgage market conditions, which can be volatile.
  • Economic downturns or rising interest rates could negatively impact mortgage servicing and origination activities.
  • Global operations expose the company to geopolitical, regulatory, and operational risks in multiple regions.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026